| FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis (NCT05000138) | Jewish General Hospital | 2022-06-10 |
| Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency (NCT05435781) | Marianne Christina Klose | 2022-06-07 |
| Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement (NCT04888221) | Assistance Publique - Hôpitaux de Paris | 2021-09-24 |
| Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis (NCT05168475) | Cambridge University Hospitals NHS Foundation Trust | 2021-07-14 |
| Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers (NCT04885829) | Syneos Health | 2021-05-31 |
| Abatacept for the Treatment of Giant Cell Arteritis (NCT04474847) | University of Pennsylvania | 2021-03-29 |
| Giant Cell Arteritis - Optimization of Diagnostics (NCT05248906) | Rigshospitalet, Denmark | 2021-03-19 |
| PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS (NCT04664465) | University Hospital, Brest | 2021-03-18 |
| Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering (NCT04012905) | University Hospital, Caen | 2021-03-03 |
| A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis (NCT04633447) | Janssen Research & Development, LLC | 2020-12-10 |
| Improved Diagnostics and Monitoring of Polymyalgia Rheumatica (NCT04519580) | Kresten Krarup Keller | 2020-09-14 |
| Rheumatology Patient Registry and Biorepository (NCT04402086) | Yale University | 2020-08-04 |
| Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery Biopsy (NCT04554290) | Central Hospital, Nancy, France | 2020-08-01 |
| Vascular MRI Evaluation in Giant Cell Arteritis (VEGA) (NCT05865054) | University of Pennsylvania | 2020-07-29 |
| Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe (NCT04397237) | Pitié-Salpêtrière Hospital | 2020-06-10 |
| Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course (NCT04204876) | University Hospital, Basel, Switzerland | 2020-05-28 |
| COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases (NCT04335747) | Salome Kristensen | 2020-04-23 |
| Collection and Analysis of the Clinical and Biological Characteristics of Patients Treated for Giant Cells ARTEitis (Horton's Disease) (NCT04142515) | Centre Hospitalier Universitaire de Nīmes | 2020-02-01 |
| MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial (NCT03892785) | Centre Hospitalier Universitaire Dijon | 2020-01-27 |
| Evaluation of PET/CT of Cephalic Arteries for the Diagnosis of Giant Cell Arteritis (NCT05246540) | Centre Hospitalier Universitaire Dijon | 2020-01-01 |
| Comparison of 22Mhz and 18Mhz High-frequency Probes for the Ultrasound Study of Temporal Arteries in Patients Suspected of Having Giant Cell Arteritis (NCT04204512) | University Hospital, Brest | 2019-12-17 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA). (NCT03923738) | Hoffmann-La Roche | 2019-08-05 |
| Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease (NCT03656627) | Alliance Foundation Trials, LLC. | 2019-06-27 |
| TARGET GCAT Registry (NCT04049071) | University of Leeds | 2019-05-13 |
| Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (NCT03482479) | University of Pennsylvania | 2019-02-04 |
| A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis (NCT03765788) | Novartis Pharmaceuticals | 2019-01-30 |
| Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab (NCT03745586) | Insel Gruppe AG, University Hospital Bern | 2018-12-01 |
| Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA (NCT03600805) | Sanofi | 2018-11-20 |
| KPL-301 for Subjects With Giant Cell Arteritis (NCT03827018) | Kiniksa Pharmaceuticals, Ltd. | 2018-09-20 |
| Assessment of Giant Cell Arteritis Medical Practices in France (NCT03658889) | Chugai Pharma France | 2018-08-02 |
| Journey of Patients With Vasculitis From First Symptom to Diagnosis (NCT03410290) | University of Pennsylvania | 2018-01-11 |
| An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA) (NCT03202368) | Hoffmann-La Roche | 2017-10-25 |
| Polymyalgia Rheumatica and Giant Cell Arteritis (NCT02985424) | Svendborg Hospital | 2017-05-01 |
| Ustekinumab for the Treatment of Giant Cell Arteritis (NCT02955147) | Massachusetts General Hospital | 2016-12-01 |
| VCRC Tissue Repository (NCT02967068) | University of Pennsylvania | 2016-11-01 |
| Validation of a Diagnostic Algorithm of Giant Cell Arteritis (NCT02703922) | Poitiers University Hospital | 2016-08-29 |
| Giant Cell Arteritis and PET Scan (GAPS) Study (NCT02771483) | Royal North Shore Hospital | 2016-05-15 |
| Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis (NCT02531633) | GlaxoSmithKline | 2015-10-16 |
| Study of Circulating Microparticles in Giant Cell Arteritis (NCT02333708) | University Hospital, Caen | 2015-09-01 |
| Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission. (NCT03244709) | Hospital of Prato | 2015-01-01 |
| Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell Arteritis (NCT03765424) | University of Aarhus | 2014-10-01 |
| Diagnostic Accuracy of FDG PET/CT of Cranial Arteries in GCA (NCT03409913) | University of Aarhus | 2014-10-01 |
| FDG Uptake in Large-Vessel Giant Cell Arteritis After Short-term, High-Dose Steroid Treatment (NCT03285945) | University of Aarhus | 2014-10-01 |
| Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis (NCT02257866) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2014-09-29 |
| VCRC Patient Contact Registry Patient-Reported Data Validation Study (NCT02190942) | University of South Florida | 2014-05-01 |
| Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study. (NCT01910038) | Centre Hospitalier Universitaire Dijon | 2013-11-08 |
| Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell Arteritis (NCT01588483) | Universitaire Ziekenhuizen KU Leuven | 2012-03-01 |
| Educational Needs of Patients With Systemic Vasculitis (NCT02190929) | University of South Florida | 2012-03-01 |
| Vasculitis Illness Perception (VIP) Study (NCT02190916) | University of South Florida | 2011-10-01 |
| Tocilizumab for Patients With Giant Cell Arteritis (NCT01450137) | Insel Gruppe AG, University Hospital Bern | 2011-09-01 |
| Reproductive Health in Men and Women With Vasculitis (NCT02176070) | University of South Florida | 2011-02-01 |
| American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis (NCT01066208) | University of Oxford | 2011-01-01 |
| One-Time DNA Study for Vasculitis (NCT01241305) | University of Pennsylvania | 2010-10-01 |
| Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis (NCT01795456) | The Cleveland Clinic | 2010-08-01 |
| Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL) (NCT00974883) | University of Oxford | 2010-06-01 |
| Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis (NCT01400464) | University Hospital, Caen | 2009-07-01 |
| Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis (NCT00556439) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2008-12-01 |
| HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis (NCT00305539) | Assistance Publique - Hôpitaux de Paris | 2006-05-01 |
| Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) (NCT04102930) | University of Leeds | 2005-06-10 |
| A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis (NCT00076726) | Centocor, Inc. | 2003-11-01 |
| Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. (NCT00138983) | UMC Utrecht | 2000-05-01 |
| Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases (NCT00006055) | Fairview University Medical Center | 2000-03-01 |
| Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis (NCT00004686) | The Cleveland Clinic | 1994-02-01 |